{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:15:04Z","timestamp":1778811304395,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","award":["20K07604"],"award-info":[{"award-number":["20K07604"]}]},{"name":"RIKEN Incentive Research Projects"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310112"],"award-info":[{"award-number":["JP20fk0310112"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09655-y","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:31:40Z","timestamp":1751538700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["miRNA-29b-1-5p mediates an antiviral activity by targeting the HBV entry receptor in human hepatocytes"],"prefix":"10.1038","volume":"15","author":[{"given":"Luc","family":"Gailhouste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Furutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Yang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Toguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Yanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Watashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaji","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"9655_CR1","unstructured":"World Health Organization. Hepatitis B: Fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b (2024)"},{"key":"9655_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G. & Ott, J. J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet 386, 1546\u20131555 (2015).","journal-title":"Lancet"},{"key":"9655_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","volume":"479\u2013480","author":"C Seeger","year":"2015","unstructured":"Seeger, C. & Mason, W. S. Molecular biology of hepatitis B virus infection. Virology 479\u2013480, 672\u2013686 (2015).","journal-title":"Virology"},{"key":"9655_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104925","volume":"182","author":"S Tsukuda","year":"2020","unstructured":"Tsukuda, S. & Watashi, K. Hepatitis B virus biology and life cycle. Antiviral Res. 182, 104925 (2020).","journal-title":"Antiviral Res."},{"key":"9655_CR5","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/hep.28025","volume":"62","author":"TJ Liang","year":"2015","unstructured":"Liang, T. J. et al. Present and future therapies of hepatitis B: From discovery to cure. Hepatology 62, 1893\u20131908 (2015).","journal-title":"Hepatology"},{"key":"9655_CR6","doi-asserted-by":"publisher","first-page":"12546","DOI":"10.1021\/acs.jmedchem.2c01097","volume":"65","author":"S Chen","year":"2022","unstructured":"Chen, S., Zhang, L., Chen, Y. & Fu, L. Inhibiting sodium taurocholate cotransporting polypeptide in HBV-related diseases: From biological function to therapeutic potential. J. Med. Chem. 65, 12546\u201312561 (2022).","journal-title":"J. Med. Chem."},{"key":"9655_CR7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1, e00049 (2012).","journal-title":"Elife"},{"key":"9655_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","volume":"58","author":"T Volz","year":"2013","unstructured":"Volz, T. et al. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. J. Hepatol. 58, 861\u2013867 (2013).","journal-title":"J. Hepatol."},{"key":"9655_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert, L. F. R. & MacRae, I. J. Regulation of microRNA function in animals. Nat. Rev. Mol. Cell Biol. 20, 21\u201337 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9655_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"9655_CR11","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","volume":"148","author":"JT Mendell","year":"2012","unstructured":"Mendell, J. T. & Olson, E. N. MicroRNAs in stress signaling and human disease. Cell 148, 1172\u20131187 (2012).","journal-title":"Cell"},{"key":"9655_CR12","first-page":"437","volume":"28","author":"L Gailhouste","year":"2013","unstructured":"Gailhouste, L. & Ochiya, T. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma. Histol. Histopathol. 28, 437\u2013451 (2013).","journal-title":"Histol. Histopathol."},{"key":"9655_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857\u2013866 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"9655_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/hep.22749","volume":"49","author":"S Ura","year":"2009","unstructured":"Ura, S. et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49, 1098\u20131112 (2009).","journal-title":"Hepatology"},{"key":"9655_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/cas.14292","volume":"111","author":"K Yasukawa","year":"2020","unstructured":"Yasukawa, K. et al. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion. Cancer Sci. 111, 869\u2013880 (2020).","journal-title":"Cancer Sci."},{"key":"9655_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-019-1788-6","volume":"10","author":"L Gailhouste","year":"2019","unstructured":"Gailhouste, L. et al. MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells. Cell Death Dis. 10, 553 (2019).","journal-title":"Cell Death Dis."},{"key":"9655_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole, R. & Slack, F. J. MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov. 16, 203\u2013222 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9655_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/hep.26422","volume":"58","author":"L Gailhouste","year":"2013","unstructured":"Gailhouste, L. et al. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology 58, 1153\u20131165 (2013).","journal-title":"Hepatology"},{"key":"9655_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216139","volume":"14","author":"Y Furutani","year":"2019","unstructured":"Furutani, Y. et al. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes. PLoS ONE 14, e0216139 (2019).","journal-title":"PLoS ONE"},{"key":"9655_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","volume":"62","author":"S Bandiera","year":"2015","unstructured":"Bandiera, S., Pfeffer, S., Baumert, T. F. & Zeisel, M. B. miR-122\u2014A key factor and therapeutic target in liver disease. J. Hepatol. 62, 448\u2013457 (2015).","journal-title":"J. Hepatol."},{"key":"9655_CR21","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/v5112690","volume":"5","author":"M Thirion","year":"2013","unstructured":"Thirion, M. & Ochiya, T. Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses 5, 2690\u20132703 (2013).","journal-title":"Viruses"},{"key":"9655_CR22","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1096\/fj.11-187781","volume":"25","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J. 25, 4511\u20134521 (2011).","journal-title":"FASEB J."},{"key":"9655_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.147068","volume":"853","author":"K Fujita","year":"2023","unstructured":"Fujita, K. et al. Pegylated interferon therapy-related microRNA-6126 downregulates sodium taurocholate cotransporting polypeptide expression in hepatocytes. Gene 853, 147068 (2023).","journal-title":"Gene"},{"key":"9655_CR24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","volume":"443","author":"M Iwamoto","year":"2014","unstructured":"Iwamoto, M. et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem. Biophys. Res. Commun. 443, 808\u2013813 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9655_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41420-021-00515-y","volume":"7","author":"L Gailhouste","year":"2021","unstructured":"Gailhouste, L. et al. Epigenetic reprogramming promotes the antiviral action of IFNalpha in HBV-infected cells. Cell Death Discov. 7, 130 (2021).","journal-title":"Cell Death Discov."},{"key":"9655_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","volume":"23","author":"K Paunovska","year":"2022","unstructured":"Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23, 265\u2013280 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"9655_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle, M., El-Daly, S. M., Fabbri, M. & Calin, G. A. Noncoding RNA therapeutics\u2014challenges and potential solutions. Nat. Rev. Drug Discov. 20, 629\u2013651 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9655_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.omtn.2017.04.007","volume":"7","author":"MB Maepa","year":"2017","unstructured":"Maepa, M. B., Ely, A., Grayson, W. & Arbuthnot, P. Sustained inhibition of HBV replication in vivo after systemic injection of AAVs encoding artificial antiviral primary microRNAs. Mol. Ther. Nucleic Acids 7, 190\u2013199 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"9655_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers, M. M. & Haagmans, B. L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 20, 270\u2013284 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"9655_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40265-021-01474-5","volume":"81","author":"C Hum","year":"2021","unstructured":"Hum, C. et al. MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19. Drugs 81, 517\u2013531 (2021).","journal-title":"Drugs"},{"key":"9655_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/hep.27694","volume":"62","author":"D Slijepcevic","year":"2015","unstructured":"Slijepcevic, D. et al. Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+)-taurocholate cotransporting polypeptide knockout mice. Hepatology 62, 207\u2013219 (2015).","journal-title":"Hepatology"},{"key":"9655_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/hep.27240","volume":"61","author":"FM Vaz","year":"2015","unstructured":"Vaz, F. M. et al. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype. Hepatology 61, 260\u2013267 (2015).","journal-title":"Hepatology"},{"key":"9655_CR33","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.ajpath.2015.01.028","volume":"185","author":"Y Ishida","year":"2015","unstructured":"Ishida, Y. et al. Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice. Am. J. Pathol. 185, 1275\u20131285 (2015).","journal-title":"Am. J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09655-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:31:43Z","timestamp":1751538703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09655-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9655"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09655-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23725"}}